Image for Chimeric antigen receptor (CAR) T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy

Chimeric Antigen Receptor (CAR) T-cell therapy is an innovative cancer treatment that involves modifying a patient’s own immune cells. Doctors take T-cells, a type of white blood cell, from the patient’s blood and edit them in a lab to better recognize and attack cancer cells. These modified cells, called CAR T-cells, are then infused back into the patient. Once inside, they seek out and destroy cancer cells more effectively than before. This approach is particularly used for certain types of blood cancers, offering new hope for patients where traditional treatments may have failed.

Additional Insights

  • Image for Chimeric antigen receptor (CAR) T-cell therapy

    Chimeric Antigen Receptor (CAR) T-cell therapy is a type of cancer treatment that modifies a patient's own immune cells, called T-cells, to better recognize and attack cancer cells. Doctors extract T-cells from the patient's blood and engineer them in a lab to express a CAR, which helps them identify specific proteins on the surface of cancer cells. After this modification, the enhanced T-cells are infused back into the patient, where they seek out and destroy the cancer cells more effectively, offering a targeted approach to treat certain types of blood cancers, such as leukemia and lymphoma.